Unknown

Dataset Information

0

MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer.


ABSTRACT: PURPOSE:To compare clinical outcomes of MR-based versus CT-based high-dose-rate interstitial brachytherapy (ISBT) for vaginal recurrence of endometrioid endometrial cancer (EC). METHODS AND MATERIALS:We reviewed 66 patients with vaginal recurrent EC; 18 had MR-based ISBT on a prospective clinical trial and 48 had CT-based treatment. Kaplan-Meier survival modeling was used to generate estimates for local control (LC), disease-free interval (DFI), and overall survival (OS), and multivariate Cox modeling was used to assess prognostic factors. Toxicities were evaluated and compared. RESULTS:Median followup was 33 months (CT 30 months, MR 35 months). Median cumulative equivalent dose in 2-Gy fractions was 75.5 Gy for MR-ISBT and 73.8 Gy for CT-ISBT (p = 0.58). MR patients were older (p = 0.03) and had larger tumor size (>4 cm vs. ? 4 cm) compared to CT patients (p = 0.04). For MR-based versus CT-based ISBT, 3-year KM rate for local control was 100% versus 78% (p = 0.04), DFI was 69% versus 55% (p = 0.1), and OS was 63% versus 75% (p = 0.81), respectively. On multivariate analysis, tumor Grade 3 was associated with worse OS (HR 3.57, 95% CI 1.25, 11.36) in a model with MR-ISBT (HR 0.56, 95% CI 0.16, 1.89). Toxicities were not significantly different between the two modalities. CONCLUSION:Despite worse patient prognostic features, MR-ISBT was associated with a significantly better (100%) 3-year local control, comparable survival, and improved DFI rates compared to CT. Toxicities did not differ compared to CT-ISBT patients. Tumor grade contributed as the most significant predictor for survival. Larger prospective studies are needed to assess the impact of MR-ISBT on survival outcomes.

SUBMITTER: Kamran SC 

PROVIDER: S-EPMC5698152 | biostudies-literature | 2017 Nov - Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer.

Kamran Sophia C SC   Manuel Matthias M MM   Catalano Paul P   Cho Linda L   Damato Antonio L AL   Lee Larissa J LJ   Schmidt Ehud J EJ   Viswanathan Akila N AN  

Brachytherapy 20170817 6


<h4>Purpose</h4>To compare clinical outcomes of MR-based versus CT-based high-dose-rate interstitial brachytherapy (ISBT) for vaginal recurrence of endometrioid endometrial cancer (EC).<h4>Methods and materials</h4>We reviewed 66 patients with vaginal recurrent EC; 18 had MR-based ISBT on a prospective clinical trial and 48 had CT-based treatment. Kaplan-Meier survival modeling was used to generate estimates for local control (LC), disease-free interval (DFI), and overall survival (OS), and mult  ...[more]

Similar Datasets

| S-EPMC5422203 | biostudies-literature
| S-EPMC6545480 | biostudies-literature
| S-EPMC4355179 | biostudies-literature
| S-EPMC6171910 | biostudies-literature
| S-EPMC7969770 | biostudies-literature
| S-EPMC4906382 | biostudies-other
| S-EPMC3922177 | biostudies-other
| S-EPMC11294723 | biostudies-literature
| S-EPMC3759987 | biostudies-literature
| S-EPMC4200177 | biostudies-other